精神分裂症(Schizophrenia)是一种复杂的慢性精神障碍,主要表现为思维、情感、感知和行为的多方面异常,常伴有现实检验能力的受损。
1.阳性症状(异常体验)
. 幻觉:以幻听为主(如评论性、命令性声音),偶有视幻觉。
. 妄想:被害、被控制等脱离现实的坚信(如坚信被跟踪或拥有超能力)。
. 思维形式障碍:语无伦次、联想松散或答非所问。
. 行为紊乱:紧张症或不可预测的冲动行为。
2.阴性症状(功能缺损)
. 情感钝化:面部表情减少,情感反应迟钝。
. 意志减退:主动性丧失,如长期卧床不修边幅。
. 言语贫乏:语言内容空洞,信息量显著下降。
社交退缩:回避人际互动,兴趣范围缩小。
3.认知功能障碍
. 工作记忆、执行功能及注意力受损,影响日常决策能力。
发病机制假说:
. 多巴胺系统异常:中脑边缘系统过度活跃(阳性症状),前额叶多巴胺不足(阴性症状)。
. 神经发育异常:孕期感染、围产期并发症可能导致皮层连接异常。
. 遗传因素:一级亲属患病风险达10%,全基因组研究发现108个风险位点。
. 环境触发:童年创伤、大麻滥用(尤其青少年期)显著增加发病风险。
需满足至少两项核心症状(其中一项必须是阳性症状),持续6个月以上,并导致社会功能显著下降。
阶梯式治疗策略:
1.急性期治疗
. 第二代抗精神病药(奥氮平、利培酮等)为首选,需监测代谢综合征。
. 难治性病例可联用氯氮平,需定期血常规监测粒细胞缺乏。
2.巩固期治疗
. 认知行为疗法(CBT-p)针对妄想进行现实检验训练。
. 家庭心理教育改善病耻感,降低表达性情感(EE)水平。
3.康复期干预
. 社会技能训练(SST)提升就业能力
.计算机认知矫正治疗(CCRT)改善神经认知
. 阴性症状突出、发病年龄早、病前功能差者预后较差。
. 家庭支持系统完善、及时系统治疗可使20-30%患者获得功能性康复。
. 区别于分离性身份障碍(DID),非人格分裂。
. 暴力风险仅略高于常人,多数患者更易成为受害者。
. 谷氨酸能药物(如甘氨酸转运体抑制剂)进入III期临床试验。
. 数字表型分析(语音模式、运动传感器)辅助早期识别复发。
建议疑似患者尽早就诊于精神科进行结构化临床访谈(如SCID),社区精神卫生中心可提供药物管理和团队服务。疾病虽具挑战性,但循证治疗已显著改善长期预后。
Schizophrenia: A Comprehensive Overview
1. Symptoms
Schizophrenia is characterized by a range of symptoms categorized into positive, negative, and cognitive domains:
Positive Symptoms: Additions to normal behavior.
Hallucinations: Often auditory (hearing voices), but can also be visual or tactile.
Delusions: Fixed false beliefs (e.g., paranoia, grandiosity).
Disorganized Thinking/Speech: Incoherent or tangential communication.
Movement Disorders: Agitation or catatonia.
Negative Symptoms: Reductions in normal behaviors.
Avolition: Lack of motivation.
Alogia: Reduced speech output.
Anhedonia: Inability to feel pleasure.
Flat Affect: Diminished emotional expression.
Cognitive Symptoms:
Impaired executive function, attention, and working memory.
2. Causes and Risk Factors
Genetic: Higher risk with family history; polygenic inheritance.
Neurochemical: Dopamine dysregulation hypothesis (excess dopamine in mesolimbic pathway).
Brain Structure: Enlarged ventricles, reduced gray matter in some studies.
Environmental: Prenatal exposure to infections, childhood trauma, urban upbringing.
Triggers: Stressful life events, substance use (e.g., cannabis in adolescence).
3. Diagnosis
Based on DSM-5 criteria: ≥2 core symptoms (e.g., delusions, hallucinations) for ≥6 months, with functional impairment.
Differential diagnosis excludes substance-induced psychosis, bipolar disorder, or medical conditions (e.g., brain tumors).
4. Treatment
Medications:
Antipsychotics (e.g., risperidone, clozapine for treatment-resistant cases).
Side effects: Weight gain, tardive dyskinesia, metabolic issues.
Psychosocial Interventions:
Cognitive Behavioral Therapy (CBT) for psychosis.
Social skills training, family therapy, supported employment.
Early Intervention Services: Critical during first-episode psychosis.
5. Prognosis
Variable: 20-30% achieve significant improvement, while others face chronic challenges.
Factors improving outcomes: Early treatment, adherence to medication, strong support networks.
6. Misconceptions and Stigma
Not "Split Personality": Distinct from dissociative identity disorder (DID).
Violence Myth: Most individuals are non-violent; higher risk of self-harm or victimization.
Subtypes: DSM-5 no longer classifies paranoid/catatonic types; emphasizes symptom spectrum.
7. Key Considerations
Cognitive Remediation: Addresses memory/attention deficits.
Prodromal Phase: Early signs (e.g., social withdrawal) may precede acute episodes.
Stigma Reduction: Advocacy and education combat stereotypes, promoting inclusion.
Schizophrenia requires a holistic management approach integrating medical, psychological, and social support to enhance quality of life. Early intervention and sustained care are pivotal for long-term outcomes.